000			02232 a2200601 4500
005			20250513235533.0
264		0	_c20020103
008			200201s 0 0 eng d
022			_a0300-0664
024	7		_a10.1046/j.1365-2265.2001.01080.x _2doi
040			_aNLM _beng _cNLM
100	1		_aFerone, D
245	0	0	_aIn vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy. _h[electronic resource]
260			_bClinical endocrinology _cApr 2001
300			_a469-77 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcromegaly _xdrug therapy
650	0	4	_aAdrenocorticotropic Hormone _xanalysis
650	0	4	_aAdult
650	0	4	_aAminoquinolines _xtherapeutic use
650	0	4	_aAnalysis of Variance
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aCabergoline
650	0	4	_aDopamine Agonists _xtherapeutic use
650	0	4	_aErgolines _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFollicle Stimulating Hormone _xanalysis
650	0	4	_aGrowth Hormone _xanalysis
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aIndium Radioisotopes _xmetabolism
650	0	4	_aInsulin-Like Growth Factor I _xanalysis
650	0	4	_aIodine Radioisotopes _xmetabolism
650	0	4	_aLuteinizing Hormone _xanalysis
650	0	4	_aMale
650	0	4	_aOctreotide _xmetabolism
650	0	4	_aPituitary Neoplasms _xcomplications
650	0	4	_aProlactin _xanalysis
650	0	4	_aProlactinoma _xcomplications
650	0	4	_aReceptors, Dopamine _xmetabolism
650	0	4	_aReceptors, Somatostatin _xmetabolism
650	0	4	_aThyrotropin _xanalysis
650	0	4	_aTumor Cells, Cultured _xdrug effects
700	1		_aPivonello, R
700	1		_aLastoria, S
700	1		_aFaggiano, A
700	1		_aDel Basso de Caro, M L
700	1		_aCappabianca, P
700	1		_aLombardi, G
700	1		_aColao, A
773	0		_tClinical endocrinology _gvol. 54 _gno. 4 _gp. 469-77
856	4	0	_uhttps://doi.org/10.1046/j.1365-2265.2001.01080.x _zAvailable from publisher's website
999			_c11252989 _d11252989